High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc∈ receptor I

Journal of Immunology

Volumn 157, Issue 1, 1996, Pages 221-230

  Wiegand, Torsten W ^a   Williams, P Brock ^b,d   Dreskin, Stephen C ^b   Jouvin, Marie Helen ^c   Kinet, Jean Pierre ^c   Tasset, Diane ^a  

^a GILEAD SCIENCES   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d IBT Reference Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; MESSENGER RNA; OLIGONUCLEOTIDE;

ALLERGIC DISEASE; ARTICLE; DRUG BINDING SITE; DRUG RECEPTOR BINDING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIGAND BINDING; NUCLEOTIDE REPEAT; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; RECEPTOR AFFINITY; RNA SEQUENCE; SEROTONIN RELEASE;

ANTIBODY AFFINITY; BASE SEQUENCE; BINDING, COMPETITIVE; DNA; HUMANS; IMMUNOGLOBULIN E; LIGANDS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; OLIGONUCLEOTIDES; RECEPTORS, IGE; RNA; SEROTONIN ANTAGONISTS;

EID: 0029943440     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Tuerk, C., and L. Gold. 1990. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249: 505.
2. Gold, L., P. Allen, J. Binkley, D. Brown, D. Schneider, S. R. Eddy, C. Tuerk, L. Green, S. MacDougal, and D. Tasset. 1993. RNA: the shape of things to come. In The RNA World. R. F. Gesteland and J. F. Atkins, eds. Cold Spring Harbor Laboratory Press, Plainview, p. 497.
3. Gold, L. 1995. Oligonucleotides as research, diagnostic, and therapeutic agents. J. Biol. Chem. 270:13581.
4. Gesteland, R. F., and J. F. Atkins. 1993. The RNA World. Cold Spring Harbor Laboratory Press, Plainview.
5. Gold, L., B. Polisky, O. Uhlenbeck, and M. Yarus. 1995. Diversity of oligonucleotide functions. Annu. Rev. Biochem. 64:763.
6. Kauffman, S. A., and E. D. Weinberger. 1989. The NK model of rugged fitness landscapes and its application to maturation of the immune response. J. Theor. Biol. 141:211.
7. Roitt, I. M., J. Brostoff, and D. K. Male. 1993. Immunology. Mosby, London.
8. Schneider, D., C. Tuerk, and L. Gold. 1992. Selection of high affinity RNA ligands to the bacteriophage R17 coat protein. J. Mol. Biol. 228:862.
9. Tuerk, C., S. MacDougal, and L. Gold. 1992. RNA pseudoknots that inhibit human immunodeficiency virus type I reverse transcriptase. Proc. Natl. Acad. Sci. USA 89:6988.
10. Bartel, D. P., M. L. Zapp, M. R. Green, and J. W. Szostak. 1991. HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA. Cell 67:529.
11. Ringquist, S., T. Jones, E. E. Snyder, T. Gibson, I. Boni, and L. Gold. 1995. High-affinity RNA ligands to Escherichia coli ribosomes and ribosomal protein S1: comparison of natural and unnatural binding sites. Biochemistry 34:3640.
12. Kubik, M. F., A. W. Stephens, D. Schneider, R. A. Marlar, and D. Tasset. 1994. High-affinity RNA ligands to human alpha-thrombin. Nucleic Acids Res. 22: 2619.
13. Lin, Y., Q. Qiu, S. C. Gill, and S. D. Jayasena. 1994. Modified RNA sequence pools for in vitro selection. Nucleic Acids Res. 22:5229.
14. Jellinek, D., C. K. Lynott, D. B. Rifkin, and N. Janjic. 1993. High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding. Proc. Natl. Acad. Sci. USA 90:11227.
15. Jellinek, D., L. S. Green, C. Bell, and N. Janjic. 1994. Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth factor. Biochemistry 33:10450.
16. Davies, J., U. Von Ahsen, and R. Schroeder. 1993. Antibiotics and the RNA world: a role for low-molecular-weight effectors in biochemical evolution? In The RNA World. R. F. Gesteland and J. F. Atkins, eds. Cold Spring Harbor Laboratory Press, Plainview, pp. 185-204.
17. Jenison, R. D., S. C. Gill, A. Pardi, and B. Polisky. 1994. High-resolution molecular discrimination by RNA. Science 263:1425.
18. Ellington, A. D., and J. W. Szostak. 1992. Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures. Nature 355:850.
19. Illangasekare, M., G. Sanchez, T. Nickles, and M. Yarus. 1995. Aminoacyl-RNA synthesis catalyzed by an RNA. Science 267:643.
20. Wilson, C., and J. W. Szostak. 1995. In vitro evolution of a self-alkylating ribozyme [see comments]. Nature 374:777.
21. Ekland, E. H., J. W. Szostak, and D. P. Bartel. 1995. Structurally complex and highly active RNA ligases derived from random RNA sequences. Science 269: 364.
22. Capron, A., J. P. Dessaint, M. Capron, and R. J. Pierce. 1992. Schistosomiasis: from effector and regulation mechanisms in rodents to vaccine strategies in humans. Immunol. Invest. 21:409.
23. Gounni, A. S., B. Lamkhioued, K. Ochiai, Y. Tanaka, E. Delaporte, A. Capron, J. P. Kinet, and M. Capron. 1994. High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 367:183.
24. Sutton, B. J., and H. J. Gould. 1993. The human IgE network. Nature 366:421.
25. Metzger, H., G. Alcaraz, R. Hohman, J. P. Kinet, V. Pribluda, and R. Quarto. 1986. The receptor with high affinity for immunoglobulin E. Annu. Rev. Immunol. 4:419.
26. Metzger, H. 1992. The receptor with high affinity for IgE. Immunol. Rev. 125:37.
27. Helm, B., P. Marsh, D. Vercelli, E. Padlan, H. Gould, and R. Geha. 1988. The mast cell binding site on human immunoglobulin E. Nature 331:180.
28. Nissim, A., M. H. Jouvin, and Z. Eshbar. 1991. Mapping of the high affinity Fc epsilon receptor binding site to the third constant region domain of IgE. EMBO J. 10:101.
29. Shimizu, A., I. Tepler, P. N. Benfey, E. H. Berenstein, R. P. Siraganian, and P. Leder. 1988. Human and rat mast cell high-affinity immunoglobulin E receptors: characterization of putative alpha-chain gene products. Proc. Natl. Acad. Sci. USA 85:1907.
30. Riske, F., J. Hakimi, M. Mallamaci, M. Griffin, B. Pilson, N. Tobkes, P. Lin, W. Danho, J. Kochan, and R. Chizzonite. 1991. High affinity human IgE receptor (Fc epsilon RI): analysis of functional domains of the alpha-subunit with monoclonal antibodies. J. Biol. Chem. 266:11245.
31. Beaven, M. A., and H. Metzger. 1993. Signal transduction by Fc receptors: the Fc epsilon RI case. Immunol. Today 14:222.
32. Bialy, H. 1993. Quietly rationalizing drug discovery. Biotechnology 11:1516.
33. Gould, H. J. 1992. The interaction between immunoglobulin E and its high-affinity receptor. In Genetics of Asthma. S. T. Holgate and M. K. Church, eds. Gower, London, p. 309.
34. Kinet, J. P., U. Blank, A. Brini, M. H. Jouvin, H. Kuster, O. Mejan, and C. Ra. 1991. The high-affinity receptor for immunoglobulin E: a target for therapy of allergic diseases. Int. Arch. Allergy Appl. Immunol. 94:51.
35. Presta, L. G., S. J. Lahr, R. L. Shields, J. P. Porter, C. M. Gorman, B. M. Fendly, and P. M. Jardieu. 1993. Humanization of an antibody directed against IgE. J. Immunol. 151:2623.
36. Dreskin, S. C., P. K. Goldsmith, W. Strober, L. A. Zech, and J. I. Gallin. 1987. Metabolism of immunoglobulin E in patients with markedly elevated serum immunoglobulin E levels. J. Clin. Invest. 79:1764.
37. Takebe, Y., M. Seiki, J. Fujisawa, P. Hoy, K. Yokota, K. Arai, M. Yoshida, and N. Arai. 1988. SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol. 8:466.
38. Lin, A. Y., B. Devaux, A. Green, C. Sagerstrom, J. F. Elliott, and M. M. Davis. 1990. Expression of T cell antigen receptor heterodimers in a lipid-linked form. Science 249:677.
39. Dreskin, S. C., V. S. Pribluda, and H. Metzger. 1989. IgE receptor-mediated hydrolysis of phosphoinositides by cytoplasts from rat basophilic leukemia cells. J. Immunol. 142:4407.
40. Schwarzbaum, S., A. Nissim, I. Alkalay, M. C. Ghozi, D. G. Schindler, Y. Bergman, and Z. Eshhar. 1989. Mapping of murine IgE epitopes involved in IgE-Fc epsilon receptor interactions. Eur. J. Immunol. 19:1015.
41. Pieken, W. A., D. B. Olsen, F. Benseler, H. Aurup, and F. Eckstein. 1991. Kinetic characterization of ribonuclease-resistant 2′-modified hammerhead ribozymes. Science 253:314.
42. Fitzwater, T., and B. Polisky. 1996. A SELEX primer. Methods Enzymol. In press.
43. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
44. Gill, S. C., S. E. Weitzel, and P. H. von Hippel. 1991. Escherichia coli sigma 70 and NusA proteins. I. Binding interactions with core RNA polymerase in solution and within the transcription complex. J. Mol. Biol. 220:307.
45. Ramkumar, V., G. L. Stiles, M. A. Beaven, and H. Ali. 1993. The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J. Biol. Chem. 268:16887.
46. Wilson, A. P. M., D. Moreira-Machado, N. Rhodes, T. B. Ahmad, C. E. Pullar, and B. A. Helm. 1993. Revisiting the basophil degranulation test. J. Clinical Immunoassay 16:91.
47. Milligan, J. F., D. R. Groebe, G. W. Witherell, and O. C. Uhlenbeck. 1987. Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Acids Res. 15:8783.
48. Zuker, M. 1989. On finding all suboptimal foldings of an RNA molecule. Science 244:48.
49. Williamson, J. R. 1993. Guanine quartets. Curr. Opin. Struct. Biol. 3:357.
50. Padlan, E. A., and D. R. Davies. 1986. A model of the Fc of immunoglobulin E. Mol. Immunol. 23:1063.
51. Helm, B. A., Y. Ling, C. Teale, E. A. Padlan, and M. Bruggemann. 1991. The nature and importance of the inter-epsilon chain disulfide bonds in human IgE. Eur. J. Immunol. 21:1543.
52. Miller, P. S., P. Bhan, and L.-S. Kan. 1993. Syntheses and interactions of oligodeoxyribonucleotides containing 2′-amino-2′-deoxyuridine. Nucleosides and Nucleotides 12:785.
53. Williamson, J. R., M. K. Raghuraman, and T. R. Cech. 1989. Monovalent cation-induced structure of telomeric DNA: the G-quartet model. Cell 59:871.
54. Schultze, P., F. W. Smith, and J. Feigon. 1994. Refined solution structure of the dimeric quadruplex formed from the Oxytricha telomeric oligonucleotide d(GGGGTTTTGGGG). Structure 2:221.